drugset / Trial / NCT07577999
The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
NaSingle-groupOpen-labelSupportive care
Summary
This will be an open-label, single group supportive care pilot study in which patients are given cannabinoid gummies in the perioperative setting to alleviate RC/UD symptoms and improve quality of life. The primary objective will be to evaluate the safety and tolerability of a cannabigerol supplement used perioperatively (from 14 days prior to surgery to 30 days following surgery) by patients undergoing radical cystectomy with urinary diversion (RC/UD).
Timeline
- Start
- 2027-07
- Primary completion
- 2028-05
- Completion
- 2028-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabigerol | Small molecule | 6.25 mg | Oral |
| Subject | Cannabigerol | Small molecule | 12.5 mg | Oral |
| Subject | Cannabigerol | Small molecule | 25 mg | Oral |